ArticleScientific reports2020
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Annamaria Ruzzo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.